vs
科睿唯安（CLVT）与Life360, Inc.（LIF）财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是Life360, Inc.的4.2倍（$617.0M vs $146.0M）。Life360, Inc.净利率更高（88.8% vs 0.5%，领先88.3%）。Life360, Inc.同比增速更快（26.4% vs -6.9%）。科睿唯安自由现金流更多（$89.2M vs $36.6M）。过去两年Life360, Inc.的营收复合增速更高（36.6% vs -0.3%）
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
Life360是一家主打家庭安全与互联服务的科技企业，核心产品涵盖实时位置共享、紧急求助预警、驾驶行为分析及身份防盗保护服务，主要面向北美、欧洲、亚太消费市场，营收大多来自其分级付费订阅套餐。
CLVT vs LIF — 直观对比
营收规模更大
CLVT
是对方的4.2倍
$146.0M
营收增速更快
LIF
高出33.3%
-6.9%
净利率更高
LIF
高出88.3%
0.5%
自由现金流更多
CLVT
多$52.6M
$36.6M
两年增速更快
LIF
近两年复合增速
-0.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $617.0M | $146.0M |
| 净利润 | $3.1M | $129.7M |
| 毛利率 | 66.8% | 75.1% |
| 营业利润率 | 6.7% | 6.1% |
| 净利率 | 0.5% | 88.8% |
| 营收同比 | -6.9% | 26.4% |
| 净利润同比 | 101.6% | 1425.9% |
| 每股收益（稀释后） | $0.00 | $1.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLVTLIF
| Q4 25 | $617.0M | $146.0M | ||
| Q3 25 | $623.1M | $124.5M | ||
| Q2 25 | $621.4M | $115.4M | ||
| Q1 25 | $593.7M | $103.6M | ||
| Q4 24 | $663.0M | $115.5M | ||
| Q3 24 | $622.2M | $92.9M | ||
| Q2 24 | $650.3M | $84.9M | ||
| Q1 24 | $621.2M | $78.2M |
净利润CLVTLIF
| Q4 25 | $3.1M | $129.7M | ||
| Q3 25 | $-28.3M | $9.8M | ||
| Q2 25 | $-72.0M | $7.0M | ||
| Q1 25 | $-103.9M | $4.4M | ||
| Q4 24 | $-191.8M | $8.5M | ||
| Q3 24 | $-65.6M | $7.7M | ||
| Q2 24 | $-304.3M | $-11.0M | ||
| Q1 24 | $-75.0M | $-9.8M |
毛利率CLVTLIF
| Q4 25 | 66.8% | 75.1% | ||
| Q3 25 | 65.0% | 78.0% | ||
| Q2 25 | 67.2% | 78.4% | ||
| Q1 25 | 65.1% | 80.6% | ||
| Q4 24 | 65.7% | 74.0% | ||
| Q3 24 | 66.2% | 75.4% | ||
| Q2 24 | 67.2% | 75.0% | ||
| Q1 24 | 64.9% | 76.7% |
营业利润率CLVTLIF
| Q4 25 | 6.7% | 6.1% | ||
| Q3 25 | 7.1% | 4.6% | ||
| Q2 25 | 1.1% | 1.7% | ||
| Q1 25 | -3.5% | 2.1% | ||
| Q4 24 | -9.4% | 4.9% | ||
| Q3 24 | 3.5% | -5.3% | ||
| Q2 24 | -36.9% | -2.8% | ||
| Q1 24 | 0.8% | -8.2% |
净利率CLVTLIF
| Q4 25 | 0.5% | 88.8% | ||
| Q3 25 | -4.5% | 7.9% | ||
| Q2 25 | -11.6% | 6.1% | ||
| Q1 25 | -17.5% | 4.2% | ||
| Q4 24 | -28.9% | 7.4% | ||
| Q3 24 | -10.5% | 8.3% | ||
| Q2 24 | -46.8% | -12.9% | ||
| Q1 24 | -12.1% | -12.5% |
每股收益（稀释后）CLVTLIF
| Q4 25 | $0.00 | $1.53 | ||
| Q3 25 | $-0.04 | $0.11 | ||
| Q2 25 | $-0.11 | $0.08 | ||
| Q1 25 | $-0.15 | $0.05 | ||
| Q4 24 | $-0.27 | $0.14 | ||
| Q3 24 | $-0.09 | $0.09 | ||
| Q2 24 | $-0.46 | $-0.15 | ||
| Q1 24 | $-0.14 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $329.2M | $494.3M |
| 总债务越低越好 | $4.3B | — |
| 股东权益账面价值 | $4.8B | $548.2M |
| 总资产 | $11.1B | $959.7M |
| 负债/权益比越低杠杆越低 | 0.89× | — |
8季度趋势，按日历期对齐
现金及短期投资CLVTLIF
| Q4 25 | $329.2M | $494.3M | ||
| Q3 25 | $318.7M | $455.7M | ||
| Q2 25 | $362.6M | $432.7M | ||
| Q1 25 | $354.0M | $168.9M | ||
| Q4 24 | $295.2M | $159.2M | ||
| Q3 24 | $388.5M | $159.0M | ||
| Q2 24 | $376.4M | $160.8M | ||
| Q1 24 | $361.8M | $73.4M |
总债务CLVTLIF
| Q4 25 | $4.3B | — | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.5B | — | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.6B | — | ||
| Q1 24 | $4.6B | $5.2M |
股东权益CLVTLIF
| Q4 25 | $4.8B | $548.2M | ||
| Q3 25 | $4.9B | $391.4M | ||
| Q2 25 | $5.0B | $366.7M | ||
| Q1 25 | $5.0B | $376.3M | ||
| Q4 24 | $5.1B | $358.5M | ||
| Q3 24 | $5.5B | $339.7M | ||
| Q2 24 | $5.6B | $326.7M | ||
| Q1 24 | $5.9B | $239.8M |
总资产CLVTLIF
| Q4 25 | $11.1B | $959.7M | ||
| Q3 25 | $11.2B | $787.5M | ||
| Q2 25 | $11.4B | $753.6M | ||
| Q1 25 | $11.5B | $455.4M | ||
| Q4 24 | $11.5B | $441.6M | ||
| Q3 24 | $12.0B | $427.4M | ||
| Q2 24 | $12.1B | $405.9M | ||
| Q1 24 | $12.5B | $318.8M |
负债/权益比CLVTLIF
| Q4 25 | 0.89× | — | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.90× | — | ||
| Q4 24 | 0.88× | — | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | 0.79× | 0.02× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $159.9M | $36.8M |
| 自由现金流经营现金流 - 资本支出 | $89.2M | $36.6M |
| 自由现金流率自由现金流/营收 | 14.5% | 25.1% |
| 资本支出强度资本支出/营收 | 11.5% | 0.2% |
| 现金转化率经营现金流/净利润 | 51.58× | 0.28× |
| 过去12个月自由现金流最近4个季度 | $365.3M | $86.8M |
8季度趋势，按日历期对齐
经营现金流CLVTLIF
| Q4 25 | $159.9M | $36.8M | ||
| Q3 25 | $181.1M | $26.4M | ||
| Q2 25 | $116.3M | $13.3M | ||
| Q1 25 | $171.2M | $12.1M | ||
| Q4 24 | $141.3M | $12.3M | ||
| Q3 24 | $202.9M | $6.3M | ||
| Q2 24 | $126.2M | $3.3M | ||
| Q1 24 | $176.2M | $10.7M |
自由现金流CLVTLIF
| Q4 25 | $89.2M | $36.6M | ||
| Q3 25 | $115.5M | $25.6M | ||
| Q2 25 | $50.3M | $12.7M | ||
| Q1 25 | $110.3M | $11.9M | ||
| Q4 24 | $59.1M | $11.2M | ||
| Q3 24 | $126.3M | $6.3M | ||
| Q2 24 | $60.3M | $3.2M | ||
| Q1 24 | $111.8M | — |
自由现金流率CLVTLIF
| Q4 25 | 14.5% | 25.1% | ||
| Q3 25 | 18.5% | 20.6% | ||
| Q2 25 | 8.1% | 11.0% | ||
| Q1 25 | 18.6% | 11.5% | ||
| Q4 24 | 8.9% | 9.7% | ||
| Q3 24 | 20.3% | 6.8% | ||
| Q2 24 | 9.3% | 3.8% | ||
| Q1 24 | 18.0% | — |
资本支出强度CLVTLIF
| Q4 25 | 11.5% | 0.2% | ||
| Q3 25 | 10.5% | 0.6% | ||
| Q2 25 | 10.6% | 0.6% | ||
| Q1 25 | 10.3% | 0.1% | ||
| Q4 24 | 12.4% | 1.0% | ||
| Q3 24 | 12.3% | 0.0% | ||
| Q2 24 | 10.1% | 0.1% | ||
| Q1 24 | 10.4% | 0.0% |
现金转化率CLVTLIF
| Q4 25 | 51.58× | 0.28× | ||
| Q3 25 | — | 2.70× | ||
| Q2 25 | — | 1.90× | ||
| Q1 25 | — | 2.75× | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
LIF
暂无分部数据
